4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000004
Chief Financial Officer sold 4,105 shares at $24.10 ($98,931)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barnett Eva Renee Chief Financial Officer | 2025-01-08 | Sale | −4,105 | $24.10 | $98,931 | 327,064 | D |
| Open-market sales · 4,105 sh · avg $24.10 · $98,931 | |||||||
Loading xslF345X05/wk-form4_1736543549.xml…